These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 6458235)
1. Pharmacokinetics, protein binding, and predicted extravascular distribution of moxalactam in normal and renal failure subjects. Peterson LR; Bean B; Fasching CE; Korchik WP; Gerding DN Antimicrob Agents Chemother; 1981 Sep; 20(3):378-81. PubMed ID: 6458235 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of moxalactam in patients with renal failure and during hemodialysis. Srinivasan S; Neu HC Antimicrob Agents Chemother; 1981 Sep; 20(3):398-400. PubMed ID: 6458236 [TBL] [Abstract][Full Text] [Related]
4. [Pharmacokinetics of moxalactam in adults]. Humbert G; Leroy A; Fillastre JP Sem Hop; 1983 Jun; 59(26):1963-7. PubMed ID: 6310787 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of moxalactam in subjects with normal and impaired renal function. Leroy A; Humbert G; Fillastre JP Antimicrob Agents Chemother; 1981 Jun; 19(6):965-71. PubMed ID: 6455967 [TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics of moxalactam in renal failure. Wright N; Wills PJ; Wise R J Antimicrob Chemother; 1981 Nov; 8(5):395-9. PubMed ID: 6459316 [No Abstract] [Full Text] [Related]
7. Pharmacokinetics of moxalactam in patients with renal insufficiency. Lam M; Manion CV; Czerwinski AW Antimicrob Agents Chemother; 1981 Mar; 19(3):461-4. PubMed ID: 6454383 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of moxalactam in subjects with various degrees of renal dysfunction. Bolton WK; Scheld WM; Spyker DA; Overby TL; Sande MA Antimicrob Agents Chemother; 1980 Dec; 18(6):933-8. PubMed ID: 6453555 [TBL] [Abstract][Full Text] [Related]
9. Single- and multiple-dose pharmacokinetics of moxalactam in normal subjects. Israel KS; Black HR; Brier GL; Wolny JD; DeSante KA Antimicrob Agents Chemother; 1982 Jul; 22(1):94-102. PubMed ID: 6214998 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of moxalactam in patients with normal and impaired renal function. Aronoff GR; Sloan RS; Luft FC J Infect Dis; 1982 Mar; 145(3):365-9. PubMed ID: 6460824 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of moxalactam and cefazolin compared in normal volunteers. Srinivasan S; Fu KP; Neu HC Antimicrob Agents Chemother; 1981 Feb; 19(2):302-5. PubMed ID: 6214989 [TBL] [Abstract][Full Text] [Related]
14. [Comparative pharmacokinetics of moxalactam and other cephalosporins]. Fourtillan JB; Brisson AM Sem Hop; 1983 Jun; 59(26):1968-71. PubMed ID: 6310788 [TBL] [Abstract][Full Text] [Related]
15. Comparison of cefotaxime and moxalactam pharmacokinetics and tissue levels. Wise R; Baker S; Livingston R Antimicrob Agents Chemother; 1980 Sep; 18(3):369-71. PubMed ID: 6252833 [TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacology of moxalactam in patients with malignant disease. Estey EH; Weaver SS; Ho DH; Bodey GP Antimicrob Agents Chemother; 1981 Apr; 19(4):639-44. PubMed ID: 6454389 [TBL] [Abstract][Full Text] [Related]
17. Moxalactam and cefazolin: comparative pharmacokinetics in normal subjects. Scheld WM; Spyker DA; Donowitz GR; Bolton WK; Sande MA Antimicrob Agents Chemother; 1981 Apr; 19(4):613-9. PubMed ID: 6454387 [TBL] [Abstract][Full Text] [Related]